Abstract
INTRODUCTION
The laparoscopic bariatric procedure commonly referred to as "sleeve gastrectomy" (LSG) is a left partial gas trectomy of the fundus and body to create a long tubular gastric conduit constructed along the lesser curve of the stomach [1] . LSG was initially proposed as a first-stage procedure to reduce the mortality and postoperative morbidity of more complex bariatric procedures in higherrisk patients [2] , such as the duodenal switch, to complete the biliopancreatic diversion or the RouxenY gastric bypass (RYGB) in a second stage. Soon, it was noted that many patients frequently lost sufficient weight such that a secondstage operation became unnecessary [3] . LSG is not merely a restrictive procedure. LSG provokes a rapid gastric emptying of solid food, accelerates intestinal transit and induces a favourable change in the gut hormones, thereby facilitating weight loss through restriction and appetite suppression, given the reduction in the ghrelin levels after resection of the gastric fundus [37] . Since then, LSG has been performed as a primary and definitive bariatric procedure in patients whose weight and medical condition are not sufficiently severe to require a complex bariatric operation, moving to a second stage only in those selected patients in which weight loss was inadequate [8] .
Eventually, LSG was performed in some patients with special conditions in which the usual bariatric operations might be too aggressive [9] . The number of LSGs performed worldwide has grown exponentially over the last decade, because it appears to be an easier and safer technique [1013] . Many surgeons now perform LSG as their standard bariatric operation [3] . The advantages of the LSG include its technical sim plicity, shorter operative time, maintenance of bowel integrity and preservation of the pylorus [3, 10] . The long term problems associated with other complex bariatric procedures, including internal hernias and small bowel obstruction are avoided with LSG. In addition, patients who underwent LSG had fewer nutritional deficiencies than that did patients who underwent RYGB or bilio pancreatic diversion [14] . The LSG can later be modified by a laparoscopic approach if required, to a more complex procedure (such as RYGB or duodenal switch) in patients who develop severe gastroesophageal reflux symptoms or those who regain weight.
LSG has proven highly effective at achieving durable weight loss and comorbidity reduction over the short and intermediate terms and is comparable in some aspects to RYGB, the current gold standard in bariatric surgery [7, 1518] . However, some questions must be answered regarding the longterm results of LSG because there are a limited data from longterm studies and because of the variability in both the reported followup among series and the rate of patients lost to followup.
The aim of this study was to assess the safety and outcomes of patients who underwent a LSG as a primary bariatric procedure in analysing mortality, postoperative morbidity rate, late complications and evolution of weight loss after 5 years of followup.
MATERIALS AND METHODS

Patients selection and study design
From 2006 to January 2016, data from patients who underwent a LSG as a single procedure treating morbid obesity were collected in an electronic database (Microsoft Access 2003 Microsoft Corporation, Redmond, QA, United States) for analysis. All study participants, or their legal guardian, provided informed written consent prior to study enrolment. The study was officially registered under the identification number researchregistry 1580 on researchregistry.com.
The indications for LSG included patients with body mass index (BMI) less than 45 kg/m 2 , primary procedure in superobese patients as the initial stage of a twostaged approach for weight loss (RYGB or BPD in 2 stages), adolescents (under 18 years old of age) with morbid obesity and obese patients with impaired medical conditions or other important comorbidities such as liver cirrhosis.
The first endpoint of this study was to assess the safety of the procedure by analysing the 30d mortality and early postoperative complications: Suture leak rate, haemorrhages, wound infection rate, deep venous thrombosis, pulmonary embolism and cardiac and pulmonary complications.
The second endpoint was to evaluate the outcome of LSG in terms of weight loss 5 years after the procedure. Weight loss was measured using BMI evolution and the percentage of excess weight loss (%EWL). Given the variability of %EWL depending on the definition of ideal body weight, we also used the percentage of excess body mass index loss (%EBMIL) [19] . Excessive BMI itself was defined as initial BMI minus 25. Values are reported as the mean ± standard deviation.
The following variables were also evaluated: Reso lution of preoperative comorbid conditions [diabetes, hypertension, obstructive sleep apnoea syndrome (OSA)], length of hospital stay and late complications (stricture, functional obstruction, gastroesophageal reflux, trocar site hernia rate).
Surgical technique
Under general anaesthesia the patients were placed in the reverse Trendelenburg position with the surgeon standing between the legs. All patients received intra venous antibiotic prophylaxis with 2 g of cefazoline. Com pression stockings were used during the operation to prevent deep vein thrombosis and thromboembolism.
The procedure was performed using 4 or 5 ports (two or three 12mm trocars and two 5mm trocars). The greater curvature of the stomach was completely freed starting from the antrum (3 cm proximal to pylorus) until the left pillar of the diaphragm and the gastroesophageal junction were completely exposed. If a hiatal hernia is identified, dissection should be carried posteriorly to achieve appropriate closure of the crus. If a hernia is found, it should be repaired [10] . A harmonic scalpel (Ultracision ® , Ethicon EndoSurgery Inc., Johnson and Johnson, Cincinnati, OH, United States) was used to divide the gastroepiploic and the short gastric vessels. Then, the adhesions of the posterior side of the stomach were dissected to achieve an appropriate sleeved stomach. The LSG was performed by sequentially firing an articulating linear stapler (Echelon Flex™ Endopath, Ethicon Endo Surgery Inc., Johnson and Johnson, Cincinnati, OH, United States). The gastric division started at 3 cm proximal to the pylorus. Two 60mm green staple cartridges (open height = 4.1 mm) were usually used to transect the antrum, and gold (3.8 mm) and blue loads (3.6 mm) were later applied at the gastric corpus and fundus. The whole fundus had to be removed. Special attention was required at that point to avoid rotation and functional obstruction of the sleeve by ensuring equal (and not excessive) traction on both walls of the stomach. It is of utmost importance to align the stapler firings properly to avoid excessive narrowing, especially at the level of the incisura angularis (Figure 1 ).
The calibration of the LSG was obtained using a 34 F oral gastric tube (1.13 cm). The gastric stapled line was always oversewn with a 2/0 absorbable running suture (Monoplus ® , B. Braun, Melsungen, Germany) in the 125 initial cases. A bovine pericardial strip (BPSPeristrip) was used in 5 patients. Since 2014, bioabsorbable membranes (Gore Seamguard ® from WL Gore and Associates, Newark, DE, United States) were used instead of the reinforcement suture to achieve better hemostasis and reduce the suture leakage rate [15] . Intraoperative leak testing using methylene blue dye was routinely performed. A suction Blake or JacksonPratt drain was placed along the suture line. Finally, the gastric specimen was withdrawn through the right 12mm port. All 12mm wounds were closed with Monoplus ® or Monomax ® 2/0 sutures (B. Braun, Mel sungen, Germany) using an Endoclose™ trocarsite closure device (Covidien Products, Medtronic, Minneapolis, MN, United States).
Patients started to walk 8 to 12 h after the procedure. A liquid diet was initiated on the first postoperative day and was implemented for two weeks. The patients were usually discharged on the second or third postoperative day. The treatment included oral analgesia, protonpump inhibitors (PPI) and low molecular weight heparin against deep vein thrombosis for 30 d.
Postoperative follow-up
The first follow-up control was scheduled at the medical office eight days after the procedure. Follow-up data were obtained at the medical office after 15 d, 1, 3, 6 mo, 1 year and semiannually thereafter by the surgeon who performed the procedure and by a nutritionist. All data were prospectively collected.
RESULTS
Data from 156 patients who underwent LSG until January 2016 were analysed. Of the patients, 116 (74.4%) were ). All the procedures were performed laparoscopically by the same surgeon. The mean hospital stay was 3.5 ± 0.7 d (range: 118). All patients completed the 6-mo outpatient follow-up at the medical office. The mean followup was 32.7 ± 28.5 mo (Table 1) .
The mean operating time was 95 ± 14.1 min. Con version to laparotomy was necessary in 2 patients (1.2%) due to intraoperative haemorrhage. One patient was a woman suffering from a cavernous transformation of the portal vein and the other required a lateral segmentectomy to remove a bleeding 8cm liver haemangioma.
Morbidity and mortality
No mortality was observed in this series. The total 30d postoperative complication rate was 5.1% (8/156 patients). The type and severity of complications are listed in Table 2 . A leakage in the stapleline was detected in 2 women (1.2%). The first woman (after oversewing the staple line) healed successfully with medical management 14 d after. The second (Peristrips ® reinforcement) required a laparoscopic reoperation to drain a subphrenic abscess secondary to a leak at the angle of His. No endoprosthesis or selfexpanded wallstent was needed. There was no relationship between leakage and patients' BMI, age or technical difficulties during the sleeve gastrectomy procedure. Intraoperative leak testing was not predictive of the later development of staple line leaks. No patients presented with deep vein thrombosis or pulmonary embolism.
Regarding late complications, one patient (without symptoms of previous stapleline leak) developed a gastric stricture 10 mo after the LSG and submitted to a laparoscopic gastric bypass (0.6%). Twentyfour patients (15.3%) referred to newonset symptoms suggesting gastroesophageal reflux requiring daily low-dose of PPI. One of these patients developed a hiatal hernia and underwent laparoscopic hiatoplasty and a Hill gastropexy with good outcomes. To date, three patients (1.9%) have developed a trocarsite hernia. Cholecystectomy due to symptomatic gallstones was performed during the follow up in 7 patients (4.4%); 2 of them presented with acute pancreatitis. There were no data on the cholelithiasis rate in asymptomatic patients.
Weight loss
The mean followup was 32.7 ± 28.5 mo (range 6112). There were 140 patients with at least 1 year of follow up. Fiftyone patients reached more than 5 years of followup.
The mean initial BMI was 41. , with a mean %EWL of 82.0 ± 18.8 and a mean %EBMIL of 94.9 ± 22.4 after the 1year followup. However, weight loss dropped progressively during the followup with remarkable differences among the patients ( Figure  2 ). The mean %EBMIL was 89.4 ± 27.4 at 3 years and 74.8 ± 29.4 (range: 27.2119.0) at 5 years. The evolution of mean BMI, %EWL and %EBMIL at different followup points is shown in Figure 2 and Table 3 .
The overall success rate, defined when %EWL is > 50%, was 96.1% of the patients after 1 year, 95.1% after 2 years, 89.5% after 3 years, 82.1% after 4 years and 73.0% after 5 years. It must be highlighted that the patients with a lower initial BMI, especially those with initial BMI under 40 kg/m 2 , achieve excellent results in terms of %EWL and %EBMIL (Figure 3 ).
Revisional surgery
During postoperative followup, reoperation because of weight regain from %EWL > 50% to %EWL < 30% was necessary in 4 patients (2.5%), all of them beyond 
Data are frequency counts (percentage of total).
the fourth year of followup. A 70yearold woman re ceived a laparoscopic resleeve, one patient underwent a SADI's and two received a laparoscopic RYGB.
Resolution of co-morbidities
After the first postoperative year, the rate of remission or improvement of hypertension was 71.7% (total remission in 25 patients and improvement in 3). CPAP was withdrawn in all patients with obstructive sleep apnoea (OSA). Complete remission of type 2 diabetes (T2DM) was observed in 75% (9/12) of preoperative diabetic patients (remission was considered when anti diabetic medication was discontinued and blood glucose level was under 120 mg/mL). One patient receiving preoperative insulin improved and now receives peroral antidiabetic medication.
DISCUSSION
The first endpoint of this study was to assess the safety of LSG as a primary bariatric procedure. LSG has gained popularity in recent years given its theoretical technical simplicity and low rate of complications [10, 11, 15] . However, LSG can be a very difficult procedure even for laparoscopic surgeons with advanced skills. The surgeon's experience and some technical aspects, such as the bougie size (less than 40 F) and the distance to the pylorus being less than 4 cm from the first stapling, have been previously reported as risk factors for the development of complications after a LSG [13] . The mortality rate in this series was nil and the rate of 30d severe complications related to the procedure was 1.9% (Table 1 ). The rate of stapleline leak and fistula, which is the most feared postoperative complication after LSG, was low in this series (1.2%), even when using a thin bougie to calibrate the stomach and sectioning the stomach at a short distance from the pylorus. According to the International Sleeve Gastrectomy Expert Panel [10] , the average leak rate is 1.06% ± 1.13%. There is currently no consensus on the most effective measures to prevent the leakage and fistula, but we share the concept that reinforcing the staple line (with sutures or buttressing material) during LSG can significantly reduce the leakage rate [7, 15, 20] . The method for doing so is still a matter of debate [21] . Some reports showed no differences between oversewing of the staple line and the use of buttresses [2224] . However, a systematic review of 88 included studies representing 8920 patients [15] found that the leak rate in LSG was significantly lower using absorbable membrane (Seamguard ® ) stapleline reinforcement (1.1%) than was oversewing (2.0%), bovine pericardial strip (BPSPeristrips ® ) reinforcement (3.3%), or no reinforcement (2.6%). We observed one leak after oversewing of the staple line and another after the use of Peristrips ® . No leaks were observed in the Seamguard ® subgroup but the small number of patients in this series does not allow further analysis. It must be noted that the significantly highest incidence of leaks was reported when using both sutures and buttressing material (3.6%); consequently, this approach should always be avoided [24] . The second endpoint was to evaluate the evolution of weight loss after LSG as a primary bariatric procedure. The overall results of this study reinforce the evidence that LSG was effective at achieving a significant weight loss over short and midterm followup. Comparable outcomes in terms of weight loss over a 5year period were reported at the 3 rd International Summit of Sleeve Gastrectomy [3] , with a mean percentage of excess weight loss of 62.7%, 64.7%, 64.0%, 57.3%, and 60.0% after 1, 2, 3, 4, and 5 years, respectively. These data are all consistent with other studies published to date [16, 2538] ( Table 4) . LSG outcomes are comparable to the gold standard procedure in bariatric surgery, the RYGB [6] , thus supporting the role of LSG as a standalone bariatric operation for morbid obesity. However, a significant amount of patients may regain weight over time after LSG. Longterm results of LSG still are an ongoing concern, and 10year followup data are actually scarce. Furthermore, a high rate of patients lost to longterm followup is not uncommon in previously reported series. Although weight regain was evident with time, data from our series and some longterm observational studies indicate that a significant number of patients maintained good weight loss beyond 5 years of followup (Table 4) . A recent systematic review of 16 longterm studies including 492 patients revealed the %EWL to be 62.3%, 53.8%, 43% and 54.8% at 5, 6, 7 and 8 or more years of followup, respectively [25] . Arman et al [39] reported a mean %EBMIL of 62.5% in patients who kept the simple sleeve construction (74.6% overall study series) after a mean followup of 11.7 years. It is still unclear why LSG ceases to be effective over time in terms of weight loss in some patients, but several reasons could be involved, including dilation of the gastric tube, insufficient gastric fundus resection (where ghrelin is produced) or hyperactivity of previously silent ghrelin producing cells and other hormonal changes [6, 26, 39, 40] . Inadequate adherence to aftercare changes in eating behaviour and lack of physical activity could play a role of paramount importance in patients with poorer main tenance of weight loss. A recent systematic review by Karmali et al [41] concluded that the underlying causes leading to weight regain are multifactorial and related to patient-and procedure-specific factors.
Our data showed better results regarding weight loss when the initial BMI was lower. Patients with an initial BMI less than 40 kg/m 2 registered excellent results (73% of EWL and 90.8% of EBMIL at 5 years) compared with the overall study population (Figure 3 ). Age > 60 years, preexisting comorbidities and BMI superior to 50 kg/m 2 were identified as prognostic factors of poorer outcome after LSG. Superobese patients also had poorer weight loss results in this series. These results allow us to suggest that LSG could be routinely used as a sole bariatric technique for patients whose BMI was less than [29] 2012 60 38.4 ± 5.1 57.3 57.3 Sarela [30] 2012 13 45.9 76 69 (8 yr) Rawlins [31] 2013 49 65 56 85.8 91 Sieber [32] 2014 62 43.0 ± 8.0 61.5 ± 23.4 57.4 ± 24.7 Boza [33] 2014 112 34.9 88 62.9 Liu [34] 2015 44 41.0 ± 7.0 70.5 57.2 Lemanu [35] 2015 55 50.7 56 40 Pok [36] 2015 61 37.3 ± 8.1 76.5 72.6 Alexandrou [37] 2015 30 55.5 ± 1.7 65.2 ± 6.1 56.4 ± 5.8 Perrone [38] . However, we observed high variability among patients regarding weight loss maintenance over time, even in patients with similar characteristics. No other significant differences were found between subgroups of patients probably due to the small sample of patients with 5 years of followup. Identifying preoperative predictive factors of success might be useful for developing strategies to improve bariatric surgery outcomes and patient selection. Further longterm followup randomized studies that include a larger number of patients are needed to identify which patients would benefit the most from LSG.
The last endpoint was to analyse the resolution of preoperative comorbidities in the patients who underwent a LSG. LSG allowed CPAP to be withdrawn in all patients in the series with preoperative OSA and achieved the resolution of hypertension and T2DM in more than 70%. The improvement of T2DM occurred soon after surgery, even without significant weight loss yet being achieved, and this fact could be attributed to hormonal changes, such as increased GLP1 secretion or decreased ghrelin [6] . The longterm effects of LSG on T2DM evolution are under continuous evaluation, and Aminian et al [42] recently reported a 44% of longterm relapse of T2DM after initial remission and continuous complete remission for ≥ 5 years ("cure") was achieved in only 3% of the patients. LSG and RYGB showed comparable remission rates of T2DM in a longterm observational study [18] , but a meta analysis including 6526 patients confirmed that RYGB achieved a higher diabetes remission rate (HR = 1.49, 95%CI: 1.042.12) [16] . Current data suggesting the long term superiority of RYGB over LSG in the metabolic control of T2DM could be accounted for by the greater weight loss and by a larger contribution of weightlossindependent mechanisms [4345] . In our opinion, the main limitations of this study are the sample size of the series and the heterogeneity of the patients included in the series, precluding to discover significant differences between subgroups of patients (for example, only 15 superobese patients are included in this series). In addition, only 32% (51/156) of patients reached 5years of followup. The lack of adherence to followup was reported previously, and it can be related to several issues, including the distance to the medical office and a lack of trust or rapport with the surgeon or the medical team [46] . However, the most relevant strength of this study is that all patients underwent a standardized LSG operative technique, first, because surgeon expertise is a key issue to lower the complications rate [13, 24] and second, because there were no technical differences that may influence the weight loss results. We always tried to perform a more restrictive LSG by using a thinner bougie and beginning the dissection 3 cm from the pylorus to achieve greater weight loss, as suggested by Baltasar et al [8, 31] . In addition, the longterm followup of the patients was always carried out by the same surgeon who per formed the procedure.
In conclusion, a LSG built with a narrow 34 F bougie and starting 3 cm from the pylorus, proved to be safe and highly effective in terms of weight loss as a stand alone procedure, especially in patients with preoperative BMI lower than 40 kg/m 2 . In our opinion, LSG could be accepted as the first stand-alone procedure for morbidly obese patients with low BMI. Prospective randomized trials analysing longterm results (beyond ten years of followup) will help elucidate whether LSG is comparable to more aggressive techniques.
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COMMENTS
Background
The number of laparoscopic sleeve gastrectomies (LSGs) performed worldwide as a primary bariatric procedure has grown exponentially in recent years, given the simplicity of the technique, the low complication rate and the good shortand mid-term results regarding weight loss and the resolution of co-morbidities. However, the long-term results of LSG still are an ongoing concern because a significant amount of patients may regain weight over time after LSG.
Research frontiers
Bariatric surgery is safe and efficient and allows not only to lose weight but treat conditions such diabetes, hypertension and sleep apnoea in morbidly obese people. Probably, the indications of bariatric and metabolic surgery will increase in the future treating such comorbidities, given its good results and low morbimortality.
Innovations and breakthroughs
The current prospective study suggests that LSG could be the procedure of choice for those morbid patients with a low preoperative body mass index (BMI) and without severe comorbidities. However, strict nutritional and behavioural monitoring and follow-up by the surgical team seem to be of paramount importance.
Applications
This study provides additional evidence supporting the role of LSG as a standalone procedure for morbidly obese patients, particularly in patients with a low preoperative BMI.
Terminology
Sleeve gastrectomy: Is a left partial gastrectomy of the fundus and body to create a long tubular gastric conduit constructed along the lesser curve of the stomach. The body mass index (BMI) is the main parameter to assess morbid obesity and is defined as the body mass (weight in kilograms) divided by the square of the body height and is universally expressed in units of kg/m 2 . The changes in weight and BMI expressed by means of percentage of excess weight loss and percentage of excess of BMI loss help to evaluate the success of bariatric surgery.
Peer-review
The article addresses an important entity and many newly qualified surgeons may find this article interesting. 
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